Overview

PeriOperative ISchemic Evaluation-3 Trial

Status:
Active, not recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

Summary

This study is a multicentre, international, randomized controlled trial of tranexamic acid (TXA) versus placebo and, using a partial factorial design, of a perioperative hypotension-avoidance versus hypertension-avoidance strategy.

Phase:

Phase 3

Details

Lead Sponsor:

Population Health Research Institute

Treatments:

Tranexamic Acid